Research Article

Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney Disease: A Retrospective Longitudinal Observational Study

Table 2

Association of the risk of microalbuminuria with visit-to-visit variability of HbA1c, measured as 4 indices using a Cox proportional hazards model.

IndexHR (95% CI)a valueb valuecPS-matched subjects
HR (95% CI) valueb

HbA1c-SD
 Q111
 Q21.60 (1.11-2.30)0.0110.012
 Q31.52 (1.00-2.30)0.0500.076
 Q41.77 (1.12-2.79)0.0140.0153.18 (1.06-9.58)0.040
HbA1c-CV
 Q111
 Q21.51 (1.06-2.17)0.0240.022
 Q31.19 (0.79-1.77)0.4040.407
 Q41.61 (1.06-2.44)0.0260.0251.54 (0.57-4.17)0.391
HbA1c-AUC
 Q111
 Q21.28 (0.89-1.85)0.1830.158
 Q31.51 (1.01-2.26)0.0470.027
 Q41.60 (1.02-2.49)0.0390.0323.29 (1.13-9.61)0.027
HbA1c-HVS
 Q111
 Q21.52 (1.07-2.17)0.0190.018
 Q31.19 (0.82-1.72)0.3650.371
 Q41.33 (0.83-2.12)0.2350.2584.23 (1.51-11.85)0.006

The quartiles of each index are represented by Q1, Q2, Q3, and Q4. The lower quartile is denoted as Q1, and the upper quartile is denoted as Q4. aAdjusted by age, sex, mean HbA1c over the 3-year period, duration of diabetes, SBP, LDL-C, and presence of ischemic heart disease and heart failure at baseline. bAnalyzed using a Cox proportional hazards model. cAnalyzed using a bootstrap analysis based on 1,000 replicated datasets. HR: hazard ratio; CI: confidence interval; PS: propensity score; HbA1c-SD: internal standard deviation of HbA1c; HbA1c-CV: coefficient of variation of HbA1c; HbA1c-AUC: area under the HbA1c curve; HbA1c-HVS: HbA1c change score; SBP: systolic blood pressure; LDL-C: low-density lipoprotein cholesterol.